Animal Drug-Free Treatment
Breakthrough Treatment for Arthritis and the other conditions shown
A number of vets have been using Serrapeptase enzymes for arthritis and many other animal conditions and the signs are more than encouraging. This amazing enzyme has been successfully used on humans, without side effects for 25 years. This new animal treatment does not require a prescription and is a fraction of the cost of conventional medicines.
So far they have been giving the supplement to dogs, all severely affected with arthritis and all in a great degree of pain. There have been no side effects and pain relief has been almost total. Being a dietary supplement rather than a drug means a possible breakthrough for non-drug animal arthritis sufferers.
Serrapeptase, an enzyme derived from a controlled fermentation of the bacterial strain Serratia Serrapeptase. T-1 secretes this enzyme in a medium. The enteric coating of the tablets protects the enzyme from inaction in the acidic medium of the stomach. Manufacturers have now introduced enteric-coated granules in capsules. This is of great benefit for treating small dogs, cats, children and those unable to swallow, as they can be mixed. Serrapeptase is a stronger saseinolytic (fibrinolytic) agent than any other known alkaline neutral protease such as chymotrypsin, bromelain or pronase.
The medicinal effects of Serrapeptase for animals identified clinically are:
• Lung, sinus and other mucus problems
• Pain problems of any kind
• Inflammation (after surgery, injury etc)
• Scar tissue
Dog Arthritis Story
Mr Rich was introduced to Serrapeptase when his 13-year-old bitch was unable to walk and the drugs could do no more. With a few weeks of taking it she was up and walking again. Two years later at aged 15 she was still being kept mobile, safely without drugs and at a cheaper cost.
Horse Serrapeptase Story
In your newsletter, you have asked for feedback about Serrapeptase. I am delighted to give you mine.
I used Serrapeptase on my horse, which sustained a severe tendon injury in April 2003. By June a scan showed that he had a chronic tendonitis with much scar tissue formed, both on the tendons, in the tendon sheaths and in the surrounding ligaments. The prognosis was poor; ‘moderate to guarded for anything more than light hacking’ said the report.
I had no idea about dose, so had to make an educated guess! I fed him 10 tablets of Serrapeptase a day for 6 weeks, then 6 a day for 2 months, then 3 a day for a further 2 months. He has just been re-scanned (November 2003). To my delight, the scan showed almost a full recovery. There is minimal scarring on the tendons, and none in the tendon sheaths or ligaments. He is expected to get back to full work now.
I can now bring him back into work. I will increase the work slowly over a period of 2 -3 months, and continue on a maintenance dose of Serrapeptase (2 a day) for a while. This is a truly remarkable recovery, and I am absolutely delighted.
I will be spreading the word!